Toronto, Canada

Saija Ahonen

This inventor holds 3 USPTO granted patents. Top assignees: Ionis Pharmaceuticals, Inc., The Hospital for Sick Children. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Saija Ahonen. Retrieved from https://idiyas.com/inventor/saija-ahonen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Saija Ahonen: Innovator in Glycogen Storage Disease Research

Introduction

Saija Ahonen is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of glycogen storage diseases through his innovative research and patented methods. With a total of 3 patents, Ahonen's work focuses on advancing treatments for individuals affected by these disorders.

Latest Patents

Ahonen's latest patents include methods, compounds, and compositions for reducing the expression of GYS1 in individuals. These innovations are designed to treat, prevent, delay, or ameliorate glycogen storage diseases or disorders in those in need. His work in this area is crucial for improving the quality of life for affected individuals.

Career Highlights

Throughout his career, Saija Ahonen has worked with prominent organizations such as Ionis Pharmaceuticals, Inc. and The Hospital for Sick Children. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Tamar R Grossman and Susan M Freier, who have also played significant roles in advancing research in glycogen storage diseases.

Conclusion

Saija Ahonen's contributions to the field of glycogen storage diseases through his patents and collaborations highlight his commitment to improving patient outcomes. His innovative approaches continue to pave the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…